The Oral β-Lactamase SYN-004, Designed to Protect the Gut Microbiome from Biliary Excreted IV Antibiotics, Efficiently Degrades Intestinal Ceftriaxone in Two Phase 2a Clinical Trials

The Oral β-Lactamase SYN-004, Designed to Protect the Gut Microbiome from Biliary Excreted IV Antibiotics, Efficiently Degrades Intestinal Ceftriaxone in Two Phase 2a Clinical Trials

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open forum infectious diseases 2016-12, Vol.3 (suppl_1)
Hauptverfasser: Kokai-Kun, John, Roberts, Tracey, Sicard, Eric, Rufiange, Marianne, Fedorak, Richard, Carter, Christian, Coughlin, Olivia, Whalen, Heidi, Gottlieb, Klaus, Sliman, Joseph
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue suppl_1
container_start_page
container_title Open forum infectious diseases
container_volume 3
creator Kokai-Kun, John
Roberts, Tracey
Sicard, Eric
Rufiange, Marianne
Fedorak, Richard
Carter, Christian
Coughlin, Olivia
Whalen, Heidi
Gottlieb, Klaus
Sliman, Joseph
description
doi_str_mv 10.1093/ofid/ofw172.1060
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ofid_ofw172_1060</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_ofid_ofw172_1060</sourcerecordid><originalsourceid>FETCH-LOGICAL-c830-27dbdce1f938b216aebb75aa16eeff0a27bcc2a1bfc2f543d1ab55ec3d67db3</originalsourceid><addsrcrecordid>eNpNUMtOwzAQjBBIVKV3jvsBDdhO8zqWUEqlQhFESJwix1m3RomDbKO2v8WFv-CbcFUOXHZXq5nZnQmCS0quKMmj616qxpctTZlfJOQkGLCIZWGWx-npv_k8GFn7TgihlMQkzQfBd7lBWBnews9XuOTC8Y5bhJe3x5CQyRhu0aq1xgZcD0-mdygcOE-Zfzp4UML0teo7BGn6Dm5Uq7jZw2wnDDrPWbzCVDvlIU4JO4aZlEoo1K7de-G14Q1aWGiH1intXyhQOqP4rtcISkO59Tc3h3cYh6JVWgkPKj2itRfBmfQNR399GDzfzcriPlyu5otiugxFFpGQpU3dCKQyj7Ka0YRjXacx5zRBlJJwltZCME5rKZiMJ1FDeR3HKKIm8cxoGJCjqPdprUFZfRjVeYsVJdUh-OoQfHUMvjoEH_0CjQd8Wg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Oral β-Lactamase SYN-004, Designed to Protect the Gut Microbiome from Biliary Excreted IV Antibiotics, Efficiently Degrades Intestinal Ceftriaxone in Two Phase 2a Clinical Trials</title><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Kokai-Kun, John ; Roberts, Tracey ; Sicard, Eric ; Rufiange, Marianne ; Fedorak, Richard ; Carter, Christian ; Coughlin, Olivia ; Whalen, Heidi ; Gottlieb, Klaus ; Sliman, Joseph</creator><creatorcontrib>Kokai-Kun, John ; Roberts, Tracey ; Sicard, Eric ; Rufiange, Marianne ; Fedorak, Richard ; Carter, Christian ; Coughlin, Olivia ; Whalen, Heidi ; Gottlieb, Klaus ; Sliman, Joseph</creatorcontrib><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofw172.1060</identifier><language>eng</language><ispartof>Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Kokai-Kun, John</creatorcontrib><creatorcontrib>Roberts, Tracey</creatorcontrib><creatorcontrib>Sicard, Eric</creatorcontrib><creatorcontrib>Rufiange, Marianne</creatorcontrib><creatorcontrib>Fedorak, Richard</creatorcontrib><creatorcontrib>Carter, Christian</creatorcontrib><creatorcontrib>Coughlin, Olivia</creatorcontrib><creatorcontrib>Whalen, Heidi</creatorcontrib><creatorcontrib>Gottlieb, Klaus</creatorcontrib><creatorcontrib>Sliman, Joseph</creatorcontrib><title>The Oral β-Lactamase SYN-004, Designed to Protect the Gut Microbiome from Biliary Excreted IV Antibiotics, Efficiently Degrades Intestinal Ceftriaxone in Two Phase 2a Clinical Trials</title><title>Open forum infectious diseases</title><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpNUMtOwzAQjBBIVKV3jvsBDdhO8zqWUEqlQhFESJwix1m3RomDbKO2v8WFv-CbcFUOXHZXq5nZnQmCS0quKMmj616qxpctTZlfJOQkGLCIZWGWx-npv_k8GFn7TgihlMQkzQfBd7lBWBnews9XuOTC8Y5bhJe3x5CQyRhu0aq1xgZcD0-mdygcOE-Zfzp4UML0teo7BGn6Dm5Uq7jZw2wnDDrPWbzCVDvlIU4JO4aZlEoo1K7de-G14Q1aWGiH1intXyhQOqP4rtcISkO59Tc3h3cYh6JVWgkPKj2itRfBmfQNR399GDzfzcriPlyu5otiugxFFpGQpU3dCKQyj7Ka0YRjXacx5zRBlJJwltZCME5rKZiMJ1FDeR3HKKIm8cxoGJCjqPdprUFZfRjVeYsVJdUh-OoQfHUMvjoEH_0CjQd8Wg</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Kokai-Kun, John</creator><creator>Roberts, Tracey</creator><creator>Sicard, Eric</creator><creator>Rufiange, Marianne</creator><creator>Fedorak, Richard</creator><creator>Carter, Christian</creator><creator>Coughlin, Olivia</creator><creator>Whalen, Heidi</creator><creator>Gottlieb, Klaus</creator><creator>Sliman, Joseph</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161201</creationdate><title>The Oral β-Lactamase SYN-004, Designed to Protect the Gut Microbiome from Biliary Excreted IV Antibiotics, Efficiently Degrades Intestinal Ceftriaxone in Two Phase 2a Clinical Trials</title><author>Kokai-Kun, John ; Roberts, Tracey ; Sicard, Eric ; Rufiange, Marianne ; Fedorak, Richard ; Carter, Christian ; Coughlin, Olivia ; Whalen, Heidi ; Gottlieb, Klaus ; Sliman, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c830-27dbdce1f938b216aebb75aa16eeff0a27bcc2a1bfc2f543d1ab55ec3d67db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kokai-Kun, John</creatorcontrib><creatorcontrib>Roberts, Tracey</creatorcontrib><creatorcontrib>Sicard, Eric</creatorcontrib><creatorcontrib>Rufiange, Marianne</creatorcontrib><creatorcontrib>Fedorak, Richard</creatorcontrib><creatorcontrib>Carter, Christian</creatorcontrib><creatorcontrib>Coughlin, Olivia</creatorcontrib><creatorcontrib>Whalen, Heidi</creatorcontrib><creatorcontrib>Gottlieb, Klaus</creatorcontrib><creatorcontrib>Sliman, Joseph</creatorcontrib><collection>CrossRef</collection><jtitle>Open forum infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kokai-Kun, John</au><au>Roberts, Tracey</au><au>Sicard, Eric</au><au>Rufiange, Marianne</au><au>Fedorak, Richard</au><au>Carter, Christian</au><au>Coughlin, Olivia</au><au>Whalen, Heidi</au><au>Gottlieb, Klaus</au><au>Sliman, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Oral β-Lactamase SYN-004, Designed to Protect the Gut Microbiome from Biliary Excreted IV Antibiotics, Efficiently Degrades Intestinal Ceftriaxone in Two Phase 2a Clinical Trials</atitle><jtitle>Open forum infectious diseases</jtitle><date>2016-12-01</date><risdate>2016</risdate><volume>3</volume><issue>suppl_1</issue><issn>2328-8957</issn><eissn>2328-8957</eissn><doi>10.1093/ofid/ofw172.1060</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2328-8957
ispartof Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)
issn 2328-8957
2328-8957
language eng
recordid cdi_crossref_primary_10_1093_ofid_ofw172_1060
source DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; EZB-FREE-00999 freely available EZB journals; PubMed Central
title The Oral β-Lactamase SYN-004, Designed to Protect the Gut Microbiome from Biliary Excreted IV Antibiotics, Efficiently Degrades Intestinal Ceftriaxone in Two Phase 2a Clinical Trials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T15%3A47%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Oral%20%CE%B2-Lactamase%20SYN-004,%20Designed%20to%20Protect%20the%20Gut%20Microbiome%20from%20Biliary%20Excreted%20IV%20Antibiotics,%20Efficiently%20Degrades%20Intestinal%20Ceftriaxone%20in%20Two%20Phase%202a%20Clinical%20Trials&rft.jtitle=Open%20forum%20infectious%20diseases&rft.au=Kokai-Kun,%20John&rft.date=2016-12-01&rft.volume=3&rft.issue=suppl_1&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofw172.1060&rft_dat=%3Ccrossref%3E10_1093_ofid_ofw172_1060%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true